hydralazine has been researched along with Death, Sudden in 3 studies
Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.
Death, Sudden: The abrupt cessation of all vital bodily functions, manifested by the permanent loss of total cerebral, respiratory, and cardiovascular functions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To define better the efficacy of vasodilator therapy in the treatment of chronic congestive heart failure, we compared the effects of hydralazine and isosorbide dinitrate with those of enalapril in 804 men receiving digoxin and diuretic therapy for heart failure." | 9.07 | A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. ( Cobb, F; Cohn, JN; Dunkman, WB; Francis, G; Johnson, G; Loeb, H; Smith, R; Tristani, F; Wong, M; Ziesche, S, 1991) |
| "To define better the efficacy of vasodilator therapy in the treatment of chronic congestive heart failure, we compared the effects of hydralazine and isosorbide dinitrate with those of enalapril in 804 men receiving digoxin and diuretic therapy for heart failure." | 5.07 | A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. ( Cobb, F; Cohn, JN; Dunkman, WB; Francis, G; Johnson, G; Loeb, H; Smith, R; Tristani, F; Wong, M; Ziesche, S, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| COMENS, P | 1 |
| SCHROEDER, HA | 1 |
| Lee, TH | 1 |
| Hamilton, MA | 1 |
| Stevenson, LW | 1 |
| Moriguchi, JD | 1 |
| Fonarow, GC | 1 |
| Child, JS | 1 |
| Laks, H | 1 |
| Walden, JA | 1 |
| Cohn, JN | 1 |
| Johnson, G | 1 |
| Ziesche, S | 1 |
| Cobb, F | 1 |
| Francis, G | 1 |
| Tristani, F | 1 |
| Smith, R | 1 |
| Dunkman, WB | 1 |
| Loeb, H | 1 |
| Wong, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Regional and Systemic Hemodynamic Effects of a Long-term Administration of Amlodipine in Patients With Chronic Heart Failure Treated With a Combination of Enalapril, Furosemide and Digoxin[NCT00151619] | Phase 2 | 7 participants (Actual) | Interventional | 1999-02-10 | Terminated | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for hydralazine and Death, Sudden
| Article | Year |
|---|---|
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Chronic Disease; Death, Sudden; Double-Blind Method; Drug Administration Sc | 1991 |
2 other studies available for hydralazine and Death, Sudden
| Article | Year |
|---|---|
The L. E. cell as a manifestation of delayed hydralazine intoxication.
Topics: Child; Death; Death, Sudden; Humans; Hydralazine; Infant; Lupus Erythematosus, Systemic; Poisoning; | 1956 |
Impact of left ventricular cavity size on survival in advanced heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Body Constitution; Cause of Death; Cohort Studies; Death, | 1993 |